Nanalysis Scientific (CVE:NSCI) Hits New 1-Year Low – What’s Next?

Nanalysis Scientific Corp. (CVE:NSCIGet Free Report) hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as C$0.11 and last traded at C$0.11, with a volume of 289295 shares changing hands. The stock had previously closed at C$0.14.

Nanalysis Scientific Stock Performance

The company has a debt-to-equity ratio of 71.72, a current ratio of 1.42 and a quick ratio of 1.10. The company has a market capitalization of C$17.31 million, a P/E ratio of -2.50 and a beta of -0.48. The business has a 50-day moving average of C$0.13 and a 200-day moving average of C$0.14.

About Nanalysis Scientific

(Get Free Report)

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries.

Further Reading

Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.